Stonegate Investment Group »

Biomarin Pharma Inc convertible/ shares owned by Stonegate Investment Group

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Stonegate Investment Group from 13F filings

Historical chart of Stonegate Investment Group investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Stonegate Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Stonegate Investment Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $49k 50k 0.98
2023-12-31 $13k 13k 0.99

More positions owned by Stonegate Investment Group

Microsoft Corporation (MSFT)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Chevron Corporation (CVX)
Wal-Mart Stores (WMT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Exxon Mobil Corporation (XOM)
Home Depot (HD)
Visa Com Cl A (V)
Amazon (AMZN)
Johnson & Johnson (JNJ)
Phillips 66 (PSX)
Southern Company (SO)
Cisco Systems (CSCO)

View all positions for Stonegate Investment Group

Top funds holding Biomarin Pharma Inc convertible/

OZ Management
Millennium Management
Citigroup
Aviva
Two Sigma Investments
Calamos Advisors
Partner Fund Management
Bank of America Corporation
Lord, Abbett & Co
Sunrise Partners Limited Partnership
Centiva Capital
Jpmorgan Chase & Co
RWC Asset Management
MacKay Shields
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/